ABSTRACT
Regulation of alpha 1 -adrenergic receptors (alpha 1 ARs) is a rapidly expanding field of study due to the involvement of these receptors in several human diseases. For example, upregulation of alpha 1a AR mRNA/protein with agonist exposure has been implicated in myocardial hypertrophy.
In order to understand mechanisms underlying these findings, initial studies of human alpha 1a AR transcription have been completed and the primary promoter characterized. This review summarizes current knowledge regarding human alpha 1a AR gene transcription and compares characteristics with other adrenergic receptor genes.
INTRODUCTION
Alpha 1a ARs are G protein-coupled receptors which mediate myocardial inotropy/hypertrophy, smooth muscle contraction, and other sympathetic nervous system responses (1) .
After binding catecholamine agonist, alpha 1 ARs couple predominantly via Gq to activate phospholipase C-beta, resulting in inositol triphosphatemediated increases in intracellular calcium, as well as diacylglycerol-mediated activation of protein kinase C. Alpha 1a AR activation leads to cardiovascular smooth muscle contraction (2) and ultimately to hypertrophy and/or hyperplasia (3) (4) (5) . cDNAs encoding three alpha 1 -AR subtypes (alpha 1a , alpha 1b , alpha 1d ) have been cloned, expressed in cells, and characterized pharmacologically (6, 7) . The alpha 1a AR subtype predominates in human tissues (8) (9) (10) , and has been shown to be important in symptomatology associated with benign prostatic hyperplasia (11, 12) and the pathophysiology of myocardial hypertrophy (13) . Increased expression of alpha 1a ARs (mRNA and protein) has been demonstrated in neonatal rat myocardium upon agonist stimulation, concurrent with repression of alpha 1b and alpha 1d AR subtypes (13) . These findings underscore the importance of myocardial alpha 1a ARs in the pathophysiology of congestive heart failure where a high catecholamine state has been repeatedly demonstrated (14) . In spite of evidence of increased alpha 1a AR mRNA and protein with sympathetic stimulation, mechanisms underlying alpha 1a AR up-regulation remain unclear. Therefore, we will focus on transcriptional regulation of alpha 1 ARs in this review, with emphasis on the alpha 1a AR and comparison with other adrenergic receptor genes.
5' UNTRANSLATED REGION AND PUTATIVE REGULATORY CONSENSUS SEQUENCES
In order to study alpha 1 AR transcriptional regulation, the 5' untranslated region (5'UTR) of the gene must be characterized. Portions of the 5'UTR from alpha 1 AR genes have been cloned by several investigators: human alpha 1a AR (6.2 kb, GenBank #U72653) (15) , human alpha 1b AR (0.92 kb, GenBank #M99589) (16), rat alpha 1b AR (2.5 kb, GenBank #U83985) (17) , and rat alpha 1d AR (0.4 kb, GenBank #L31771) (18, 19) . Prokaryotic genes often include consensus sequences such as TATAA, CAAT, and GC boxes; these sequences facilitate the binding of RNA polymerase in the region of the transcription initiation site. Although TATA-less promoters have long been known to exist, initially it was thought that these types of promoters were restricted to housekeeping genes. Increasingly, TATA-less promoters have been identified for a wide range of genes, including those encoding adrenergic receptors. Thus far nine distinct adrenergic receptor subtypes have been identified (alpha1a, alpha 1b , alpha 1d , alpha 2a , alpha 2b , alpha 2c , beta 1 , beta 2 , beta 3 ). Taking species homologues into account, 1 3.1 67 --rhesus beta 1 1.4 71 --rat beta 1 1.2 72 --Beta 2 AR human beta 2 1.5 63 --rat beta 2 3.7 60 --turkey beta 2 .89 60 + -Beta 3 AR human beta 3 1.3 55 --rat beta 3 1.4 51 --Gene sequences where ≥400 bp of 5'UTR are known. Criteria for TATA include 7/7 matches (TATA A / T A A / T ). Criteria for CAAT include 7/9 matches (GG C / T CAATCT). The following adrenergic receptor genes (with their GenBank accession numbers in parenthesis) were analyzed: human alpha 1a (U72653); human alpha 1b (M99589); rat alpha 1b (U83985); rat alpha 1d (L31771); human alpha 2a (M23533); rat alpha 2a/d (RNU49747); mouse alpha 2a (MMU29693); mouse alpha 2b (M94583); human alpha 2c (HSU72648); human beta 1 (X69168); rhesus monkey beta 1 (X75540); rat beta 1 (X75538); human beta 2 (M15169); rat beta 2 (L39264); turkey beta 2 (U13978); human beta 3 (M62473); and rat beta 3 (X77483).
seventeen distinct adrenergic receptor genes have been identified with >400 bp 5'UTR. Table 1 illustrates that less than half (seven out of seventeen) of the adrenergic receptor genes characterized contain TATA or CAAT box sequences. The human alpha 1a AR contains neither TATA nor CAAT boxes, although both human alpha 1b AR and rat alpha 1b AR genes contain at least one CAAT box. In comparison, the human alpha 2a AR contains four TATA boxes, rat and mouse alpha 2a AR genes each contain one, while all but one beta-AR (the turkey beta 2 ) contain none.
IDENTIFICATION OF TRANSCRIPTION INITIATION SITES
In order to gain insight into the molecular basis of gene expression under a variety of conditions, the transcription initiation site and basal promoter region (regulatory sequences directly upstream of the transcription initiation site) need to be defined. Recently, Razik et al determined (using 5' extension and RNase protection assays) that the human alpha 1a AR gene has at least five transcription initiation sites with the main transcription initiation site located 696 bp upstream of the ATG translation start codon (20) . Multiple transcription initiation sites appear to be a common feature of alpha 1 AR genes, with the rat alpha 1b AR containing three and the human alpha 1b AR at least two transcription initiation sites (16, (21) (22) (23) . Other catecholamine receptors with multiple transcription initiation sites include the rat beta 1 AR (24) and the human dopamine 1A receptor (25).
USE OF REPORTER CONSTRUCTS TO DEFINE PROMOTERS
Characterization of basal promoter activity is often initially accomplished using reporter constructs containing serial deletions of the 5' flanking region to determine the smallest amount of sequence required for maximal basal reporter activity. Various reporters have been utilized over the last decade, with the two most common being chloramphenicol acetyl transferase (CAT) and luciferase. Luciferase reporter expression was recently utilized to define the general location of the human alpha 1a AR promoter; the functional promoter was found to reside within 125 bp upstream of the transcription initiation site in this gene (figure 1) (20) . Once the general promoter region is identified, specific mutations can be performed to further define the importance of specific factors in basal transcription of a given gene. 
TRANSCRIPTION INITIATION IN TATA-LESS PROMOTERS
In the absence of TATA or CAAT binding sites in a promoter, initiation of transcription is often associated with Sp1 binding to GC rich regions (note the relatively high GC content of the adrenergic receptor genes shown in table 1) and the presence of initiator (Inr) consensus sequences (26) (27) (28) (29) (30) . The region directly upstream from the transcription initiation start site in the human alpha 1a AR gene contains three GC boxes (G/TG/AGGCGG/TG/AG/AC/T); two of these GC boxes are found within the basic 125 bp promoter of the alpha 1a AR, and bind Sp1 (demonstrated by gel mobility shift assays) (20) . Five Inr consensus sequences ([Py] 3 [Py] 2 ANT[Py] 2 ) are also located in the 650 bp region surrounding the major transcription initiation site of the human alpha 1a AR gene (15) . This is consistent with previous findings that TATA-less promoters generally initiate transcription with RNA polymerase II at Inr sequences associated with Sp1 binding (31, 32).
MULTIPLE PROMOTERS
Multiple promoters are present in several alpha 1 AR genes. Gao, et al demonstrated three distinct alpha 1b AR mRNA species in rat liver by Northern blot analysis corresponding to three distinct promoters and transcription initiation sites (22) . Each promoter was found to contain distinct regulatory consensus sequences and transcription factor protein binding profiles, with the majority of transcription arising from the second promoter. Partial hepatectomy in the rat results in decreased overall expression of the rat liver alpha 1b AR, particularly of the dominant species of mRNA corresponding to the second promoter (22) . These events appear to be linked to a decrease in the transcription factor C/EBP during hepatocyte regeneration (33) . Hence differential activation of specific promoters occurs depending on the physiologic state of the animal. While it is tempting to speculate that the purpose of multiple promoters in a gene may be to ensure transcription in a variety of physiologic and pathologic states (e.g. "fed vs. fasting" in liver), there is as yet insufficient information to confirm this hypothesis; hence these findings may provide avenues for further investigation in a wide variety of genes. In addition, it is interesting to note that the alpha 1a AR mRNA is the only alpha 1 AR subtype mRNA present in human liver (9) . Hence alpha 1 AR hepatic regulation may differ in human versus rat liver.
CELL-SPECIFIC EXPRESSION OF ADRENERGIC RECEPTOR mRNAs
Gene expression is known to vary depending on the type of tissue examined. One explanation for this finding may be the presence of cell specific complements of transcription factors. In the human alpha 1a AR, expression occurs in many native human tissues, although expression is limited to only a few human cell lines. While human SK-N-MC neuroblastoma, DU145 prostate cancer, and Chang liver hepatoma cell lines all contain alpha 1 AR expression, DU145 and Chang liver cells contain only the alpha 1b AR subtype, while SK-N-MC cells contain alpha 1d > alpha 1a , with no alpha 1b AR (10) . After transfecting alpha 1a AR expressing cells with luciferase reporter constructs containing the human alpha 1a AR primary 125 bp promoter region, it was found that SK-N-MC cells drive higher basal luciferase activity than DU 145 or Chang liver cells (20) . These experiments support the suggestion that factors and proteins necessary for transcription of the human alpha 1a AR are cell specific.
MODULATION OF GENE EXPRESSION VIA CIS-ACTING ELEMENTS
Basal promoter activity, though essential to define, does not fully define transcriptional regulation of a gene. Regions other than the promoter exist in the 5'UTR which modulate basal adrenergic receptor gene expression. In fact, binding of transcription factors distant from the transcription initiation site have been shown to induce conformational changes thought to affect RNA polymerase II stability in the promoter region. In the human alpha 1a AR gene, both enhancer and repressor sequences have been shown to reside far upstream from the transcription initiation site (enhancer 1927-2869 bp, repressor 2869-5498 bp; figure  1 ) (20) . Several putative positive and negative response elements exist in these regions, respectively, although further investigation is required to identify specific activators and suppressors.
In addition to transcription factor-mediated enhancement and repression of basal promoter activity, gene transcription can be induced by hormones and drugs. Hormones and drugs can directly modulate gene transcription by binding to consensus sequences in the 5'UTR of a gene, or indirectly modulate expression of other transcription factors. In the adrenergic receptor family, the direct role of modulatory hormones is suggested by the presence of multiple hormone binding sites in specific genes including cAMP response elements (CRE; binding sites for the CRE binding protein CREB), glucocorticoid response elements (GRE), estrogen response elements (ERE), and insulin response elements (IRE) (table 2) (15) . Supporting this contention in the human alpha 1a AR gene is evidence that beta 3 AR stimulation of cAMP production in rat brown adipose tissue upregulates alpha 1a AR expression (34) . Furthermore, human alpha 1a AR mRNA and protein expression levels are elevated by increasing intracellular cAMP with forskolin/IBMX treatment (20) . Direct and indirect modulation of mRNA expression by hormones and drugs is an exciting area of research which may provide novel targets for therapeutic intervention in various diseases.
PERSPECTIVES
In summary, understanding regulation of human alpha 1 ARs is important, especially in light of subtype specific upregulation of the alpha 1a AR with agonist in myocardial hypertrophy. Transcriptional regulation appears to play a large role in this process and may reveal clues to receptor subtype-specific regulation in health and disease. Studies of basal and inducible transcription of alpha 1a AR and alpha 1b AR subtypes are already underway (as presented in this review), giving insight into factors important in regulating each of these genes. Further research on the effect of specific diseases on alpha 1 AR subtype transcription is now possible, potentially providing new targets for therapeutic intervention.
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